Outbreak Science
@outbreaksci
Followers
1K
Following
9
Media
1
Statuses
36K
A nonprofit to advance the science of outbreak response.
United States
Joined February 2016
This is modern Outbreak Science. Open, fast, prolific, and collaborative. Help others by taking a few minutes to provide an open, rapid review of a #2019nCoV preprint here: https://t.co/js5osMSiWG
2
17
25
We’re no longer permitted to post automated updates on preprints without paying – and we don’t have a budget for this.
0
0
0
New preprint: Understanding quantity and intensity of hospital rehabilitation using electronic health record data https://t.co/cOMfx6lp9u
#COVID19
0
0
0
New preprint: Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Pharmacy Model of Care https://t.co/dwuMuxcE7z
#COVID19
0
0
0
New preprint: Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patients https://t.co/S52YaT1XGj
#COVID19
0
0
0
New preprint: The Brazilian vaccine divide: how some municipalities are being left behind in the Covid-19 vaccine coverage https://t.co/0T2b7yYrFT
#COVID19
0
0
0
New preprint: Infection by SARS-CoV-2 with alternate frequencies of mRNA vaccine boosting for patients undergoing antineoplastic treatment for cancer https://t.co/dX0FrX833F
#coronavirus #COVID19
0
0
0
New preprint: Multiplex PCR amplicon sequencing revealed community transmission of SARS-CoV-2 lineages on the campus of Sichuan University during the outbreak of infection in Chinese Mainland at the end of 2022 https://t.co/TYM3eSwayF
#COVID19
0
0
0
New preprint: Analysing the psychosocial and health impacts of Long COVID in Pakistan: A cross sectional study https://t.co/av55K0we3b
#COVID19
1
0
0
New preprint: Researching COVID to enhance recovery (RECOVER) adult study protocol: Rationale, objectives, and design https://t.co/mVQi64C0QM
#COVID19
0
0
0
New preprint: A patient-centered view of symptoms, functional impact, and priorities in post-COVID-19 syndrome: Cross-sectional results from the Québec Action Post-COVID cohort https://t.co/3whCaD9cj0
#COVID19
0
0
0
New preprint: A distinct cross-reactive autoimmune response in multisystem inflammatory syndrome in children (MIS-C) https://t.co/jwCqWhNwXt
#COVID19
medrxiv.org
Multisystem inflammatory syndrome in children (MIS-C) is a severe, post-infectious sequela of SARS-CoV-2 infection, yet the pathophysiological mechanism connecting the infection to the broad inflam...
0
0
0
New preprint: Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021- January 2022 https://t.co/rt5mckLx0H
#COVID19
medrxiv.org
Background We aimed to estimate vaccine effectiveness (VE) against COVID-19 mortality, and to explore whether an increased risk of non-COVID-19 mortality exists in the weeks following a COVID-19...
0
0
0
New preprint: Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study https://t.co/MWPRERlXVa
#influenza #COVID19
0
0
0
New preprint: Antibodies against SARS-CoV-2 control complement-induced inflammatory responses to SARS-CoV-2 https://t.co/1qxnezqFeL
#COVID19
0
0
0
New preprint: Characterisation of populations at risk of sub-optimal dosing of artemisinin-based combination therapy in Africa
0
0
0
New preprint: INTRA- AND INTER-HOST EVOLUTION OF HUMAN NOROVIRUS IN HEALTHY ADULTS https://t.co/eJEB6hvcvg
#norovirus
0
0
0
New preprint: Increasing transmission of dengue virus across ecologically diverse regions of Ecuador and associated risk factors https://t.co/NASsv8pGyp
#Zika #chikungunya #dengue
0
0
0
New preprint: OAS3 and RNase L integrate into higher-order antiviral condensates https://t.co/CyfSz2brNL
#Zika #dengue
0
0
0
New preprint: Point-of-Care Biomarker Assay for Rapid Multiplexed Detection of CRP and IP-10 https://t.co/tZjBgFRSbU
#influenza #COVID19
0
0
0
New preprint: Societal feedback induces complex and chaotic dynamics in endemic infectious diseases https://t.co/hxrkP8NyAX
#influenza #COVID19
0
0
0